Trazium (EGYT-3,615) is an antidepressant drug which was never marketed.

[1] It has psychostimulant-like effects and its actions appear to be mediated by the dopaminergic and adrenergic systems.

[2] It was formulated as a salt with ethanesulfonic acid and given the generic name trazium esilate (INN).

[3]